September 13, 2018 07:10 AM EDT
People
Financing

Scout­ing ear­ly-stage on­col­o­gy plays, bio­phar­ma vets Detlev Bin­iszkiewicz, Scott Chap­pel make VC de­but at MPM

Amber Tong

Detlev Bin­iszkiewicz and Scott Chap­pel met at Sur­face On­col­o­gy, steer­ing the im­muno-on­col­o­gy up­start to­geth­er through a slate of pre­clin­i­cal pro­grams and a re­cent IPO. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

Ex-Kite lead­ers step in at Kyver­na as CEO ex­its af­ter land­ing year's sec­ond-biggest IPO

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

Im­mat­ics los­es Bris­tol My­er­s' sup­port on Phase 1 bis­pe­cif­ic T cell en­gager

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times